Showing results (71-80 of 490) with videos related to
Sort By:
Pageof 49
Clinical Endocrinology|October 1, 1983
The participation of hypothalamic dopamine in morphine-induced prolactin release in manG Delitala, A Grossman, G M BesserClinical Endocrinology|April 25, 2001
Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegalyF Miraki-Moud, P J Jenkins, P D Fairclough, et al.European Journal of Endocrinology|December 3, 2009
Diagnosis, management and therapeutic outcome in prepubertal Cushing's diseaseR P Dias, A Kumaran, L F Chan, et al.Clinical Endocrinology|April 18, 2007
Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrationsC C Dupuis, H L Storr, L A Perry, et al.The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activityG A Kaltsas, A M Isidori, D Florakis, et al.The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumorsM Korbonits, R A Jacobs, S J Aylwin, et al.Clinical Endocrinology|September 1, 1995
The effect of an opiate antagonist on the hormonal changes induced by hexarelinM Korbonits, P J Trainer, G M BesserEuropean Journal of Endocrinology|August 3, 2005
Predictors and rates of treatment-resistant tumor growth in acromegalyG M Besser, P Burman, A F DalyClinics in Endocrinology and Metabolism|August 1, 1986
Growth hormone releasing hormoneA Grossman, M O Savage, G M BesserClinical Endocrinology|July 17, 2001
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG]J J Mukherjee, G A Kaltsas, N Islam, et al.Pageof 49